Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty

Background. Pulmonary embolism is a serious early complication of arthroplasty procedures that can develop after deep venous thrombosis. The present study aimed to compare rivaroxaban and enoxaparin in terms of preventing DV and PE, and also in this study, we compared the complications due to these...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Necati Çiçek, İsmail Ağir, Hacı Bayram Tosun, Abuzer Uludağ, Abdulkadir Sari
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Medical emergencies. Critical care. Intensive care. First aid RC86-88.9
Acceso en línea:	https://doaj.org/article/e02581443d3a48b08e96ef81985ac2a0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e02581443d3a48b08e96ef81985ac2a0
record_format	dspace
spelling	oai:doaj.org-article:e02581443d3a48b08e96ef81985ac2a02021-11-29T00:55:45ZComparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty2090-285910.1155/2021/2945978https://doaj.org/article/e02581443d3a48b08e96ef81985ac2a02021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/2945978https://doaj.org/toc/2090-2859Background. Pulmonary embolism is a serious early complication of arthroplasty procedures that can develop after deep venous thrombosis. The present study aimed to compare rivaroxaban and enoxaparin in terms of preventing DV and PE, and also in this study, we compared the complications due to these drugs in patients undergoing elective arthroplasty. Materials and Methods. 214 patients were divided into three groups based on their treatment regimens. In group I, enoxaparin was used, in group II, rivaroxaban was used, and in group III, enoxaparin was used throughout hospitalization, and after hospital discharge, rivaroxaban was used. These three groups were compared according to the occurrence of deep venous thrombosis, pulmonary embolism, and major and minor complications. Results. Major postoperative complications occurred in 5, 15, and 6 patients in group I, II, and III, respectively. Minor postoperative complications occurred in 10, 24, and 11 patients in group I, II, and III, respectively. No significant difference was found among the three groups. Deep venous thrombosis or pulmonary embolism was not observed in any patient. Conclusion. Rivaroxaban was found to be as effective as enoxaparin in the prevention of deep venous thrombosis and other complications after arthroplasty. Moreover, oral rivaroxaban provided greater ease of use compared to subcutaneous enoxaparin. Based on these findings, we consider that rivaroxaban could be an effective alternative to enoxaparin.Necati Çiçekİsmail AğirHacı Bayram TosunAbuzer UludağAbdulkadir SariHindawi LimitedarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENEmergency Medicine International, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medical emergencies. Critical care. Intensive care. First aid RC86-88.9
spellingShingle	Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Necati Çiçek İsmail Ağir Hacı Bayram Tosun Abuzer Uludağ Abdulkadir Sari Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
description	Background. Pulmonary embolism is a serious early complication of arthroplasty procedures that can develop after deep venous thrombosis. The present study aimed to compare rivaroxaban and enoxaparin in terms of preventing DV and PE, and also in this study, we compared the complications due to these drugs in patients undergoing elective arthroplasty. Materials and Methods. 214 patients were divided into three groups based on their treatment regimens. In group I, enoxaparin was used, in group II, rivaroxaban was used, and in group III, enoxaparin was used throughout hospitalization, and after hospital discharge, rivaroxaban was used. These three groups were compared according to the occurrence of deep venous thrombosis, pulmonary embolism, and major and minor complications. Results. Major postoperative complications occurred in 5, 15, and 6 patients in group I, II, and III, respectively. Minor postoperative complications occurred in 10, 24, and 11 patients in group I, II, and III, respectively. No significant difference was found among the three groups. Deep venous thrombosis or pulmonary embolism was not observed in any patient. Conclusion. Rivaroxaban was found to be as effective as enoxaparin in the prevention of deep venous thrombosis and other complications after arthroplasty. Moreover, oral rivaroxaban provided greater ease of use compared to subcutaneous enoxaparin. Based on these findings, we consider that rivaroxaban could be an effective alternative to enoxaparin.
format	article
author	Necati Çiçek İsmail Ağir Hacı Bayram Tosun Abuzer Uludağ Abdulkadir Sari
author_facet	Necati Çiçek İsmail Ağir Hacı Bayram Tosun Abuzer Uludağ Abdulkadir Sari
author_sort	Necati Çiçek
title	Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
title_short	Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
title_full	Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
title_fullStr	Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
title_full_unstemmed	Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
title_sort	comparison of enoxaparin and rivaroxaban in the prophylaxis of deep venous thrombosis in arthroplasty
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/e02581443d3a48b08e96ef81985ac2a0
work_keys_str_mv	AT necaticicek comparisonofenoxaparinandrivaroxabanintheprophylaxisofdeepvenousthrombosisinarthroplasty AT ismailagir comparisonofenoxaparinandrivaroxabanintheprophylaxisofdeepvenousthrombosisinarthroplasty AT hacıbayramtosun comparisonofenoxaparinandrivaroxabanintheprophylaxisofdeepvenousthrombosisinarthroplasty AT abuzeruludag comparisonofenoxaparinandrivaroxabanintheprophylaxisofdeepvenousthrombosisinarthroplasty AT abdulkadirsari comparisonofenoxaparinandrivaroxabanintheprophylaxisofdeepvenousthrombosisinarthroplasty
_version_	1718407803681374208

Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty

Ejemplares similares